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Abstract
Loss of muscle mass via protein degradation is an important clinical problem but we know little of how muscle protein
degradation is regulated genetically. To gain insight our labs developed C. elegans into a model for understanding the
regulation of muscle protein degradation. Past studies uncovered novel functional roles for genes affecting muscle and/or
involved in signalling in other cells or tissues. Here we examine most of the genes previously identified as the sites of
mutations affecting muscle for novel roles in regulating degradation. We evaluate genomic (RNAi knockdown) approaches
and combine them with our established genetic (mutant) and pharmacologic (drugs) approaches to examine these 159
genes. We find that RNAi usually recapitulates both organismal and sub-cellular mutant phenotypes but RNAi, unlike
mutants, can frequently be used acutely to study gene function solely in differentiated muscle. In the majority of cases
where RNAi does not produce organismal level phenotypes, sub-cellular defects can be detected; disrupted proteostasis is
most commonly observed. We identify 48 genes in which mutation or RNAi knockdown causes excessive protein
degradation; myofibrillar and/or mitochondrial morphologies are also disrupted in 19 of these 48 cases. These 48 genes
appear to act via at least three sub-networks to control bulk degradation of protein in muscle cytosol. Attachment to the
extracellular matrix regulates degradation via unidentified proteases and affects myofibrillar and mitochondrial
morphology. Growth factor imbalance and calcium overload promote lysosome based degradation whereas calcium
deficit promotes proteasome based degradation, in both cases myofibrillar and mitochondrial morphologies are largely
unaffected. Our results provide a framework for effectively using RNAi to identify and functionally cluster novel regulators of
degradation. This clustering allows prioritization of candidate genes/pathways for future mechanistic studies.
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Introduction
Muscle mass is maintained by the balance of protein synthesis
and degradation [1], termed proteostasis [2]. Global proteostasis
has been postulated to create molecular robustness that underlies
how genetic diversity can be maintained in the absence of strong
selective pressures [3]. In muscle, proteostasis is key to maintaining
contractile ability and therefore locomotion. Additionally, because
muscle is the body’s major reservoir of protein for catabolism in
time of need, the ability to adjust to a different proteostatic state is
important to maintenance of overall physiological homeostasis in
the organism. Numerous clinical conditions are associated with
loss of muscle proteostasis. These are not limited to rare disorders
such as the muscular dystrophies, but include conditions associated
with major healthcare expenditure such as cancer (cachexia), aging
(sarcopenia), heart failure, and diabetes [4,5]. While much work
has been devoted to the problem, it is largely unknown how
extramuscular signals regulate the key proteolytic systems within
muscle. For example, in humans more than a dozen extramuscular
signals are associated with muscle atrophy [1] and four key
proteolytic systems exist [6], yet we know very little of how these
signals regulate the proteases, and in many cases we are uncertain
which proteases they regulate.
To address these gaps in knowledge, the nematode C. elegans, a
convenient organism for systems biology, has been developed as an
experimental model for studying the intramuscular signals that
regulate muscle protein degradation. It has previously been shown
that proteasome based degradation is opposed by signal from
motor neurons [7], as is suspected for human muscle. Additionally,
lysosome based degradation is opposed by a balance between pro-
degradation signal via FGFR-Ras-Raf-MAPK [8,9] and anti-
degradation signal via IGFR-PI3K-Akt-Raf [10]. Both signals are
thought to be important in mammalian muscle, although which
protease(s) they regulate remains an open question. The work to
develop C. elegans into a model for understanding the regulation of
muscle protein degradation has taken more than fifteen years, and
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has uncovered novel functional roles for genes previously identified
as the sites of mutations affecting muscle and/or as involved in
signalling in other cells or tissues.
Much work on C. elegans focuses on the genetic regulation of
behaviour [11]; thus, we currently know mutations in roughly 234
genes that affect muscle development and/or physiology in the
form of altered locomotion (unc) [12], egg laying (egl) [13], feeding
(eat) [14], defecation (exp, pbo, dec, aex) [15], or attachment (mua,
mup, rol) [16]. We anticipated that these classes of previously
identified genes would be enriched for negative regulators of
muscle protein degradation. Testing this prediction by traditional
approaches would have required several hundred genetic
constructions to place the appropriate transgenic reporter(s) of
proteostasis together with the mutation under study. We therefore
chose to use RNAi to interrogate the roles of these genes in
maintaining proteostasis. Here we use a combination of mutants
and RNA interference (RNAi) to analyse a large subset of
previously identified genes regulating muscle development and/or
physiology, with the primary aim of identifying genes regulating
muscle protein degradation. We selected 159 of the 234 genes that
affect muscle development and/or physiology for analysis. These
159 genes were selected because RNAi clones against these genes
were commercially available and past results using these clones
were published. The selection of this set of genes for analysis also
enabled our secondary aims: i) to conduct an assessment of the
accuracy and reproducibility of RNAi; ii) to conduct a compar-
ative assessment of RNAi and traditional genetic approaches for
identifying and studying genes regulating muscle protein degra-
dation. Of the 159 genes studied, 48 were identified as novel
regulators of muscle protein degradation. This finding confirmed
the prediction that the classes of genes studied would be enriched
for negative regulators of degradation. In addition to identifying
novel genes/pathways for future mechanistic work, the compar-
ative studies allowed us to develop a strategy for integrating new
RNAi experiments with the past genetic and pharmacologic
approaches to this problem. Utilizing this strategy we have
clustered the 48 genes into 3 functional groups. Two of these
groups associate new genes with known signalling networks while
the third group appears to represent at least one new signalling
network. Thus, our strategy allows newly identified genes to be
prioritized for future studies of either novel regulators of
degradation or modifiers of known signalling networks.
Results
RNAi feeding produces accurate functional data that are
largely reproducible
Compared to traditional genetic analysis [12], the use of RNAi
is relatively recent [17]. We were therefore concerned about
reproducibility and reliability of results obtained by RNAi [18].
From the 234 genes that affect muscle development and/or
physiology we identified 159 genes for which RNAi feeding vectors
were used in published large scale RNAi based screens [19,20,21].
We used these vectors and found false positive and negative rates
consistent with past suggestions for this RNAi technique [20];
,1% and 39% respectively, based upon consistency of behav-
ioural and/or developmental phenotype observed by RNAi and
the known mutant phenotype (Table S1). We next compared our
results for behavioural and/or developmental defects to those
obtained by others using the same vectors (Table S1). This analysis
revealed that the majority of our observations were consistent with
past reports (Fig. S1). However, a substantial number of genes for
which RNAi had not previously been reported to produce a
behavioural and/or developmental phenotype did produce a
phenotype in our experiments that was consistent with the known
mutant phenotype. Together, these results suggest that use of
RNAi feeding vectors that are known to produce a phenotype,
along with appropriate replicates and controls, can produce a low
false negative rate (3–5% in this study; Fig. S1). Given that 6% of
our results recapitulate a mutant phenotype but a different
developmental/behavioural phenotype was previously reported by
RNAi in a wild-type genetic background (Fig. S1), we suspect that
10% (false positives [,1%]+false negatives [3%]+phenotypic
divergence [6%]) is a realistic estimate for the lower limit of
observed experimental discrepancies of bacterial feeding vector
RNAi experiments in C. elegans. We will further address the issue of
incomplete knockdown below.
Identification of genes affecting sub-cellular muscle
compartments
Past work using transgene-coded reporter proteins in C. elegans
has shown that in some conditions that promote bulk protein
degradation in muscle cytosol, nuclear and myofibrillar proteins
are largely unaffected [7,8,9,10,22,23], while mitochondria are
affected in some cases but not others (LAJ & NJS unpublished
observations). This is similar to the situation in humans, where
distinct regulation of sub-cellular compartments in muscle is
suspected [24]. Therefore, in addition to cytosolic protein content,
we assessed myofibrillar and mitochondrial structure in response
to chronic (inter-generation) RNAi treatment throughout devel-
opment, and followed up positive findings with additional acute
(intra-generation) RNAi treatments in fully developed adults
(Fig. 1, Fig. 2, Fig. S2). An acute (intra-generation) effect of RNAi
implies that the gene product is required in adults to prevent these
abnormalities. Note that because the lacZ transgene used to study
cytosolic protein is only expressed until adulthood and the product
is not degraded for at least the next 72 hours [7,8,9,10,22,23],
changes in response to chronic RNAi treatment show a defect in
proteostasis without distinguishing synthesis from degradation,
whereas changes in response to acute RNAi treatment must be the
result of degradation alone. Using this approach we identified 101
genes as affecting sub-cellular muscle compartments (Fig. 2).
Cytosolic proteostasis is the most commonly affected
sub-cellular process
Both chronic and acute RNAi treatments result in muscle
compartment specific defects (Fig. 2, Fig. 3A). Strikingly, the
muscle cytosol is the compartment most likely to show an effect in
response to RNAi knockdown of one of these genes known to
affect muscle physiology and/or development (82/101). This
suggests that the biochemical prioritization in muscle treats the
soluble cytosolic proteins required to power contractions as more
dispensable for maintenance of organismal homeostasis than the
proteins that make up the contractile apparatus. This fits with the
hypothesis that proteostasis serves to provide a buffer against
individual genetic disruptions [3].
The majority of genes that affect sub-cellular muscle
compartments during development continue to do so in
fully differentiated muscle
As shown in Figure 3A, 70/101 genes identified as regulating
muscle development also appear to have a role in maintaining
terminally differentiated muscle (e.g. negatively regulating cyto-
solic degradation, myofibril disassembly, mitochondrial fragmen-
tation) as evidenced by muscle defects in response to acute RNAi
treatment. Intriguingly, more genes (23) are required for the
proper development of all three compartments than appear to be
Sub-Cellular Defects in C. elegans Muscle Mutants
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important for the maintenance of all three compartments in
terminally differentiated muscle (7 genes). This may suggest that,
in C. elegans, more genes have been subject to selection for proper
development than for proper maintenance of adult muscle and/or
that it is easier to genetically perturb muscle during development
than in adulthood. This is in apparent contrast to the function of
insulin-like signalling which is important for metabolic capacity
both during development and in adults [25].
RNAi feeding produces sub-cellular phenotypes even in
the absence of whole organism behavioural or
developmental phenotypes
Large-scale RNAi screens and gene knockout studies have
reported that disruption of many genes produces no effects visible
at the level of the whole organism. It is therefore important to ask
whether knockdown of many individual genes causes no overt
phenotype due to functional redundancy or compensation, or if
the phenotype resulting from knockdown is often subtle enough to
escape detection [3]. Since the genes in the set we have knocked
down are known to have visible behavioural and/or developmen-
tal defects when mutated, it seemed possible that the RNAi-treated
animals that did not display overt phenotypes might simply have
suffered incomplete knockdown, generating potential false nega-
tives. In 58/90 cases we, like others, found no gross phenotypic
effect in response to RNAi (Fig. S1). Gratifyingly, when we
examined sub-muscular defects and combined this data with our
data on behavioural/developmental defects (Fig. 2) we found that
the majority of RNAi treatments that did not induce behavioural
or developmental phenotypes did, in fact, induce sub-cellular
defects (Fig. S1). Thus, our results appear to support the notion
that many RNAi treatments produce phenotypes that are subtle
enough to escape detection. As these sub-cellular defects result
from gene knockdown, the lack of an overt phenotype may be due
to the quantitative extent of knockdown. The ability to resist the
negative consequences of decreases in gene expression would
appear to support the notion that biological systems are robust at
the organismal level. For example, individual genes may often be
important at the molecular level, but control only small changes in
overall fitness under non-selective conditions [3,26].
Behavioural phenotypes are associated with specific
patterns of sub-cellular defects
The set of genes known to affect muscle physiology was
originally identified based upon mutational effects on several
different behavioural phenotypes. Thus, we analysed the frequen-
cy of compartment specific defects associated with each gene class.
As shown in Figure 3B, unc genes (associated with movement
defects) were less likely than the other gene classes to be associated
with defects in sub-cellular muscle compartments, perhaps because
many unc genes act principally in the nervous system and were thus
unaffected by RNAi in a wild-type strain. Expression exclusively in
neurons may account for 89% of unc genes that gave no effect
when knocked down. It is also true that 74% of unc genes that did
show sub-cellular muscle defects upon RNAi knockdown are
expressed in neurons based on expression data in WormBase [27],
but these genes may also be expressed in muscle (about half are
already reported to be). Notably, the attachment and unc genes
showed a different distribution of sub-cellular compartment defects
than the other gene classes. The attachment genes encode
products that not only anchor the contractile apparatus, but also
provide structural interaction and communication with immedi-
ately adjacent cells, including other muscle cells. Knockdowns of
attachment genes were more likely to show defects in all three
compartments assayed, whereas the unc genes were more likely to
show diverse compartment specific and multi-compartment
defects. That is, disruption of muscle attachment is less well
tolerated by various sub-cellular processes than is disruption of
contraction. Consistent with this, acute RNAi knockdown of
attachment genes in adults is most likely to give an effect in fully
developed muscle and to disrupt the same compartments disrupted
Figure 1. Sub-muscular phenotypes produced by C. elegans RNAi feeding vectors. Examples of sub-cellular phenotypes scored. Cytosolic
protein content (left), myofibrillar morphology (middle), and mitochondrial morphology (right) were scored as normal (top) or abnormal (middle and
bottom); abnormalities were only scored if they were considered moderate or major (see Materials and methods for additional details). Separate scale
bars are used for each sub-cellular phenotype (cytosol: black bar, 100 mm; myofibril: white bar, 10 mm; mitochondria: yellow bar, 10 mm). Arrows
indicate gaps in the myofibrils (white) and mitochondrial networks (yellow). The large, circular, over exposed regions in the mitochondrial images are
GFP labelled nuclei, which are all normal. The large, rounded, over exposed regions in the major effect myofibril image are aggregates of myosin and
are not normal.
doi:10.1371/journal.pone.0024686.g001
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Figure 2. Genes that affect muscle protein synthesis, degradation and/or dystrophy. Effect of RNAi on sub-cellular compartments of
muscle are displayed with data colour coded to inset legend. Data are listed for each gene named to the left. Genes are broken into classes: A) eat
mutants; B) aex, exp, pbo, dec mutants; C) mua, mup, rol mutants; D) egl mutants; E) unc mutants. Genes within each class are clustered by which
compartment(s) are effected with the root order: cytosol, myofibril, and mitochondria. Priority in rooting is given to developmental effect and the
root ordering is reflected in the order of colours in the inset legend. For comparison, presence (yellow) of organismal level phenotypes is indicated to
the right and given last priority in rooting. In all cases white indicates lack of effect. Examples of sub-cellular phenotypes that were scored are
provided in Figure 1 and genes from the same classes that did not display sub-cellular defects are shown in Figure S2. Four genes (pbo-6, dpy-2, mua-
6, unc-51) were identified as potential false positives for RNAi inducing protein degradation; these genes are indicated with asterisks as RNAi against
them may produce variable results and/or be false positives for inducing degradation.
doi:10.1371/journal.pone.0024686.g002
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during development. This latter observation suggests that muscle
cell attachment complexes are dynamic structures even in fully
differentiated muscle, and that failure to maintain them has
catastrophic consequences for muscle. Conversely, our observa-
tions with the unc genes suggest that while it may be easy to perturb
contraction, there is robust protection against catastrophic
structural problems in muscle.
Integrating RNAi knockdown and mutational analysis
In order to assess how best to integrate RNAi experiments with
our existing methods, we directly compared the use of RNAi to a
traditional genetic approach. For the comparative analysis, we
selected all muscle mutant genes that had previously been placed
together with transgenic reporters of proteostasis as part of past
and on-going work, and another group of genes for which
dominant mutant alleles existed [28]. Since RNAi acts by reducing
the amount of wild-type gene product rather than altering the
function of the gene product, we anticipated that dominant
mutant alleles (which might produce hyperfunctional gene
products) would yield opposite effects. However, this was true
for only 8 of the 14 dominant mutant alleles examined by RNAi
(Table 1, Table S2). Of the 6 alleles that gave the same phenotypic
results as RNAi, one has been described as a loss of function allele
(egl-30) and one as a dominant negative allele (unc-27), so that
similar results of mutation and RNAi knockdown are expected. Of
the remaining four genes where neither gain-of-function mutations
nor RNAi produced overt effects on muscle proteostasis, in two
instances (egl-19 and unc-58) reduction-of-function alleles also did
not grossly perturb proteostasis. Combining the dominant alleles
with the broader set of muscle mutants (Table 1, Table S2), we
find that in the majority of cases, RNAi and mutants give
concordant answers in identifying genes that are required to
maintain muscle proteostasis. The RNAi experiments took roughly
one-third to one-quarter of the time required for the genetic
constructions, demonstrating a key strength of RNAi. Only three
genes were identified by mutation alone, all from dominant gain-
of-function alleles. This suggests that combined use of dominant
Figure 3. Distribution of sub-cellular compartments affected. A)
Global analysis of data presented in Figure 2. Number of genes whose
products are required to maintain proteostasis (Cytosol), myofibrillar
morphology (Myofibril), and/or mitochondrial morphology (Mitochon-
dria) during development, as assayed by the effect of chronic, inter-
generational, RNAi treatment (Chronic, left). Number of genes whose
knockdown affects protein degradation (Cytosol), myofibrillar mainte-
nance (Myofibril), and/or mitochondrial morphology (Mitochondria) in
fully developed adult muscles, as assayed by the effect of RNAi in adults
(Acute, right). Note that acute studies were only conducted on those
genes for which a chronic effect was observed. B) Gene class analysis of
data presented in Figure 2. Sub-cellular compartments that display
defects in response to RNAi are displayed as number of genes affecting
each compartment. Graphs are displayed by gene class (labels in
middle, total number of genes in class in parenthesis) with separate
graphs for defects observed in response to chronic RNAi treatment
(Chronic, left) or in fully developed adults (Acute, right). The gene
classes that correspond to the labels are as follows: Feeding mutants,
eat; Defecation mutants, aex, exp, pbo, dec; Attachment mutants, mua,
mup, rol; Egg laying mutants, egl; Movement mutants, unc. An inset
legend identifies the affected compartments. The colour codes are the
same for A and B. The root ordering from Figure 2 is used in Figure 3B
with effected compartments starting at the 12 o’clock position and
moving clockwise (e.g. cytosol only, myofibril only, etc.); the root
ordering and clockwise rotation are reflected in the order of the inset
legend. Note that if RNAi against a gene did not produce an effect
chronically, RNAi against the gene was not tested acutely.
doi:10.1371/journal.pone.0024686.g003
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alleles and RNAi offers a promising approach to epistasis
experiments. Seventeen genes were identified by RNAi alone
suggesting that RNAi may be a more sensitive tool. In one respect
RNAi does indeed appear to be a more sensitive tool: acute RNAi
treatment in adults can reveal negative regulators of degradation
alone. Past work with this system has required use of temperature
sensitive mutants to confirm a role in negative regulation of
degradation [7,8,9,10]. For example, we can only identify twk-18
as a negative regulator of protein degradation because we were
able to induce degradation in fully developed muscle by a
temperature shift of adults carrying a dominant temperature-
sensitive allele, whereas we identified 51 potential negative
regulators of degradation using RNAi alone.
Assigning genes to functional groups regulating muscle
protein degradation
Having used RNAi to identify 51 genes whose products appear
to negatively regulate bulk cytosolic protein degradation in C.
elegans muscles, we next classified these genes into groups that act
by common pathways or mechanisms. First, we used the data from
Figure 2 to group genes according to which muscle compart-
ment(s) were affected by acute RNAi treatment. Next, we
conducted additional experiments to determine if the degradation
we observed was related to the signalling pathways previously
identified as negatively regulating cytosolic muscle protein
degradation in C. elegans [7,8,9,10]. The groups were established
as follows: i) Lysosome-autophagy cluster: degradation blocked by
unc-51 reduction-of-function mutation [10]; MAPK signalling sub-
cluster, degradation blocked by mpk-1 reduction-of-function
mutation [9]; IGFR signalling sub-cluster, degradation blocked
by daf-18 reduction-of-function mutation [10]; ii) Proteasome
cluster: degradation blocked by proteasome inhibitor MG132 [7].
By this clustering methodology it appears that at least three distinct
proteolytic mechanisms are regulated by the known muscle
mutants (Fig. 4).
Consistent with past results, genes identified as negative
regulators of lysosome or proteasome based degradation infre-
quently (4/24 genes) showed acute defects in gross myofibrillar or
mitochondrial structure, suggesting that activation of bulk
cytosolic degradation via lysosomes and proteasomes does not
Table 1. Genes identified as affecting proteostasis by mutation versus RNAi.
gene name allele encodes
Proteostasis affected
in mutant
Proteostasis affected in
response to RNAi
aex-5 sa23 Kex2/subtilisin-like Y Y
egl-30 ad805dm Gq-alpha Y Y
unc-23 e324 Chaperone Y Y
unc-52 e669 Basement membrane HSPG Y Y
e669su250ts Y Y
unc-112 r367ts Mitogen inducible Y Y
twk-18 cn110ts,dm K channel Y N
unc-43 n498dm CaM kinase Y N
unc-105 n490dm Degenerin Y N
egl-1 a487 Cell death activator N Y
egl-2 n693dm K channel N Y
egl-5 n486 TF N Y
n945 N Y
egl-15 n484 FGFR N Y
n1477 N Y
n1783 N Y
egl-36 n728dm K Channel N Y
egl-43 n1079 Zn Finger N Y
exp-3 n2372dm Calcium activated K channel N Y
unc-5 e53 Netrin Receptor N Y
unc-24 e138 Stomatin N Y
unc-32 e189 Vac H-ATPase N Y
unc-36 e251 Ca channel N Y
unc-42 e270 TF N Y
unc-47 e307 GABA transporter N Y
*unc-51 e369 Kinase N Y
unc-103 e1597dm K channel N Y
rol-6 su1006dm Collagen N Y
sqt-1 sc13 Collagen N Y
*unc-51 was identified as a potential false positive for RNAi inducing degradation.
doi:10.1371/journal.pone.0024686.t001
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Figure 4. Identified genes negatively regulate muscle protein degradation via at least three functional clusters. Genes identified as
negative regulators of protein degradation were examined for reproducibility (wt) and lack of degradation in autophagy pathway mutants (UNC-51
kinase (unc-51), Fibroblast Growth Factor pathway (mpk-1), Insulin like pathway (daf-18)) or when the proteasome was inhibited (MG132). A separate
wild-type control was used in the autophagy and MG132 experiments. Displayed results indicate the result from two independent experiments or the
consensus result from three. Degradation is denoted by red, lack of degradation by green. Results from other acute effects on muscle are listed on
the right with dystrophies indicated in red and normal morphology indicated in green. Results are clustered based on putative degradation pathway:
autophagy (top), proteasome (middle), unknown pathway(s) (bottom). The autophagy pathway is further subdivided as going through unknown
pathway(s), going through the Fibroblast Growth Factor pathway but not Insulin like pathway, or going through both the Insulin like and Fibroblast
Growth Factor pathways.
doi:10.1371/journal.pone.0024686.g004
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necessarily cause problems with other sub-cellular compartments.
The lysosome-based cluster (15 genes) was completely non-
overlapping with the proteasome-based cluster (9 genes). While
this is in apparent contrast to the functional coupling between
proteasome and autophagic pathways in non-muscle cells where
inhibition of proteasome activity enhances autophagic activity
[29], for overlap to occur in our analysis a gene would need to be a
negative regulator of both the proteasome and autophagy (N.B.
When the dominant gene data are included we do find functional
coupling between the proteasome and autophagy: Calcium is a
negative regulator of the proteasome and a positive regulator of
autophagy (Fig. 5)). The partial overlap between the MAPK-based
cluster and the lysosome-based cluster identifies 9 genes that may
impinge on signaling upstream of MPK-1 MAP kinase [9] with 3
likely acting via IGFR based signaling upstream of Raf [10]. The 6
genes in the non-overlapping set may impinge on signaling
downstream of (or in parallel to) MPK-1, yet upstream of UNC-
51.
We also identified genes that do not appear to cluster with
regulators of lysosomal or proteasomal degradation; this was the
largest group of genes identified. These genes presumably regulate
at least one additional protease although a more complex scenario
is possible, such as dual regulation (with compensation) of
proteasomes and lysosomes. However, given that knockdown of
a gene in this group frequently affects the myofibrils and/or
mitochondria (15/23 genes) it seems likely that calpains and/or
caspases are being activated. The one new negative regulator
identified by mutation alone, twk-18, appears to be in the
proteasome cluster, since protein degradation is prevented by
MG132.
Bioinformatic analysis, using WormBase [27], of genes in each
of the groups suggests that there are specific regulatory networks
awaiting confirmation via additional experiments. As examples: In
the lysosome cluster, there are two Guanine nucleotide-binding
(G) protein coupled receptor genes and a Regulator of G-protein
Signalling (RGS) gene. In the proteasome cluster we found two
netrin receptor genes, a phospholipase C (PLC) gene and an
inositol triphosphate (IP3) receptor gene. In the third cluster are a
large number of genes that are known to be involved in muscle
attachment to the extracellular matrix and the Serum Response
Factor (SRF) gene (a gene linked to muscle defects in humans
[30]). A speculative model incorporating published data [7,8,9,10]
and our new dominant allele and acute RNAi data is shown in
Figure 5.
In these additional experiments we were unable to further
replicate results previously obtained for four genes (mua-6, unc-51,
dpy-2, pbo-6), a potential false positive rate of 8% (N.B. these may
be genes for which RNAi produces variable results). This
reinforces our belief that appropriate replicates and controls can
allow RNAi to be used very effectively in identifying genes that
negatively regulate cellular processes with well-defined pheno-
types.
Discussion
We have used a combination of forward-genetic (mutational)
and reverse-genetic (RNAi) approaches to interrogate a list of
known genes for novel functions. Reassuringly, we have found that
RNAi results are largely reproducible and match results from
mutants. Key strengths of RNAi appear to be speed of use and the
Figure 5. Preliminary model of control of degradation of bulk cytosolic protein in C. elegansmuscle. Inferences from past [7,8,9,10] and
these studies are shown. Left (Blue): Degradation by an unidentified protease is negatively regulated by integrin based attachment complexes which
bind to Perlecan in the extracellular matrix. Middle (Pink): Degradation by the lysosomes is controlled by a balance of signal from Insulin/Insulin-like
Receptor (negative regulator, green lines) and autocrine Fibroblast Growth Factor signal (positive regulator, red lines). Calcium overload, signalling via
CaMKII, also promotes lysosome-based degradation. Right (Green): Intra-cellular calcium controlled by a combination of membrane depolarization
and G-protein signalling events is required to negatively regulate proteasome-based degradation. N.B. Genetic disruption of the pathway in the left
section typically yields dystrophic myofibrils, whereas disruption of the pathways in the middle or on the right typically does not.
doi:10.1371/journal.pone.0024686.g005
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ability to acutely knock down gene function in fully differentiated
adult muscle. However, a weakness of the RNAi approach appears
to be the need for more stringent controls and/or replicates in
order to achieve a high level of confidence that a gene has been
correctly identified as relevant, before proceeding to more costly
and time-consuming mechanistic studies. An important open
question is whether more controlled and reproducible dsRNA
dosing can be achieved by bacterial feeding, as this may reduce the
variability of results obtained by RNAi. A combined approach
utilizing mutants and RNAi should help offset these weaknesses, as
previously suggested [18]. For example, once genes are identified
and verified by RNAi and mutations, mutants can be used in
combination with RNAi for epistasis experiments.
Based upon studies in mammals, we would anticipate a
minimum of four regulatory subnetworks controlling protein
degradation in C. elegans muscle: one each for the proteasome,
lysosomes, calpains, and caspases. Previous work with C. elegans
established at least one subnetwork for the ubiquitin-proteasome
system [7] and the lysosomes [8,9,10]. Here we have identified
additional genes that either fit within these existing subnetworks,
or represent additional subnetworks controlling the same prote-
ases. We have also identified a group of genes that represent at
least one additional signalling system controlling at least one
additional protease, presumably calpains and/or caspases. Current
estimates suggest that there are from 1300 [31] to 8000 [32] genes
that are enriched in C. elegans muscle. Similarly there are greater
than 1000 genes for which RNAi yields an Unc phenotype, as
indexed in WormBase [27]. Since the unc genes displayed the
greatest variability in distribution of sub-cellular defects, it is
possible that further examination of genes in this class will reveal
more regulatory mechanisms than further examination of genes
for which RNAi knockdown produces phenotypes associated with
the other muscle mutant classes. Given that roughly a quarter of
the unc genes we analysed displayed protein degradation upon
knockdown, the regulation of degradation may be far more
complex than initially suspected. However, it currently seems
unlikely that these complex subnetworks regulate more than a
handful of key proteases. Thus, it may be that despite large
numbers of specific genes whose products impinge on these
subnetworks, there are a limited number of general themes by
which this network functions.
Fundamental metabolic pathways are largely conserved from
single celled organisms to mammals [33] and the attachment and
development of myofibrils is largely conserved between C. elegans
and man [34]. Thus, it may be heuristically useful to conjecture
that the general themes and some of the specific molecular
mechanisms of regulation of muscle proteostasis are also largely
conserved (even though it is already clear that the signal-
transduction systems of C. elegans are considerably simpler).
Nutritional status and use are well known to control human
muscle size. However, we know surprisingly little of how this
occurs at the molecular level. Our results point to some of the
complex molecular signals that regulate muscle size in response to
both activity and nutritional status. As altered contact with the
extracellular matrix does not appear to impinge upon the key
proteolytic systems (lysosomal, proteasomal), it may be that
mechanotransduction per se [35] does not directly contribute to
controlling degradation based muscle size changes in response to
use even though attachment to the matrix is important for growth
and maintenance/repair of muscle. This may suggest that earlier
signals, in developmental terms, provide the framework upon
which other, later signals can function to control muscle size.
Calcium would appear to be a key player in terminally
differentiated muscle, mediating the abilities to grow and shrink
in response to use (it has also previously been identified as a
regulator of proteostasis [36,37,38]). Factors that control depolar-
ization of the muscle plasma membrane, including but not limited
to contractile signal from nerves, control calcium release from the
sarcoplasmic reticulum, which in turn negatively regulates
proteasome-based protein degradation. It is an open question
whether there are specific targets of calcium, and/or if calcium
release from the sarcoplasmic reticulum (in)directly affects
proteostasis [38]. Conversely, calcium overload triggers protein
degradation via autophagy, which also is controlled by growth
factors. Given that growth factor signalling can control both
autophagy and protein synthesis via mTOR [39], one attractive
model is that CaMKII coordinates calcium overload signal
upstream of TOR, thereby allowing muscle to directly integrate
control of muscle proteostasis in response to both nutritional status
and activity. This model also suggests that there is a key temporal
element to maintenance of muscle size, since calcium overload,
and consequent protein degradation, are likely to be transient.
This is consistent with the observation in humans that protein
degradation goes up transiently following exercise [40]. Thus, our
data suggest that further mechanistic work is required in C. elegans,
and that even if identical signals are not acting in human muscle,
orthologous ones are likely to be important. More broadly, as
calcium [41], and other [42], channels can be degraded, in non-
muscle cells by the proteasome to prevent trafficking to the plasma
membrane and can also be degraded by the endosome-lysosome
system once at the plasma membrane, our results raise the
question of whether we have uncovered a fundamental, feedback
controlled, mechanism of control of proteostasis: plasma mem-
brane polarization.
Materials and Methods
Nematode handling and genetics
Nematode strains were maintained and grown at 20uC as
described [23]; temperature sensitive mutants were routinely
maintained at 16uC. All alleles used in this work are listed in
Tables 1 and S2. The transgene used for assessing muscle-specific
proteostasis and protein degradation was ccIs55 (unc-54::lacZ) with
histochemical staining for LacZ activity as described [23]. The
transgene used for assessing the myofibrils was jIs01 (myo-3::GFP), a
translational fusion of the full-length myo-3 (myosin heavy chain A)
gene to GFP, with epifluorescence microscopy as described [22].
The transgene used for assessing the mitochondria and nuclei was
ccIs4251 (Pmyo-3::MitGFP; Pmyo-3::NLS::GFP-lacZ) with epifluores-
cence microscopy as described [17]. Many strains containing one
of these transgenes and mutant alleles of ‘‘muscle genes’’ were
constructed specifically for this work, while others were earlier
constructed in the Jacobson lab. All strains were constructed using
standard techniques [12]. Full details of constructions and strain
genotypes are available upon request.
RNAi screening of behavioural, developmental and sub-
cellular phenotypes
RNAi using bacterial feeding vectors was performed essentially
as described [19,20] using PD55 (ccIs55 V), PJ727 (jIs01; ccIs55 V),
and CB5600 (ccIs4251 I; him-8(e1489) IV). RNAi feeding vector
clones used in these studies are listed in Table S1. Chronic RNAi
exposure experiments were conducted by placing 3–4 L4-stage
hermaphrodite worms onto NGM RNAi plates containing seeded
bacteria expressing dsRNA for each gene and then incubating for
72–96 hours at 20uC. Progeny were then scored for developmen-
tal phenotypes with young adults scored for muscle dystrophies
and cytosolic protein levels by LacZ staining. An additional
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examination of muscle dystrophies and cytosolic protein levels
were made in adults again 24 hours later. L4 hermaphrodites from
the F1 generation were then transferred to newly seeded NGM
RNAi plates with the same bacteria for examination of the F2
generation as above. Developmental/behavioural phenotypes
scored were: Unc (uncoordinated movement), Rol (rolling
movement), Bmd (abnormal body morphology), Dpy (short fat
appearance), Pvl (protrusion from the vulva), Rup (rupture from
the vulva), Ste (sterile), Egl (egg laying defective), and Gro (long
period of development and/or growth arrest). Developmental
phenotypes were recorded if .10% of worms on the plate showed
a phenotype and also if the same phenotype was observed in both
generations, even in fewer than 10% of total worms. Sub-cellular
phenotypes scored were: Cytosolic protein content (normal,
abnormal), myofibrillar morphology (normal, abnormal), mito-
chondrial morphology (normal, abnormal); see Fig. 1 for examples
of normal and abnormal. In all cases abnormalities deemed minor
(e.g. not appreciably different from vector control) were scored
normal and abnormal if moderate and/or severe (in comparison to
the vector control) in at least 20% of worms on the slide. Defects,
within an individual worm, were classed as moderate as follows: i)
cytosolic protein content: at least a 30% loss of stain (e.g. intensity);
ii) myofibrillar morphology: at least 2 disorganized or broken
myofibrils in at least two muscles; iii) mitochondrial morphology:
loss of at least 25% of the mitochondrial network in at least two
muscles. Defects, within an individual worm, were classed as major
as follows: i) cytosolic protein content: at least a 90% loss of stain
(e.g. intensity); ii) myofibrillar morphology: at least a 90% lack of
recognizable myofibrils in at least two muscles; iii) mitochondrial
morphology: at least an 80% lack of networked mitochondria
network in at least two muscles. Genes that were identified as
negatively regulating muscle dystrophy or cytosolic protein content
in chronically treated animals were then examined for effects of
acute RNAi exposure. For acute RNAi exposure, worms were
roughly age synchronized [23] and grown to young adulthood on
non-RNAi bacteria at 20uC (approximately 48 hours). Young
adult animals were manually transferred to NGM RNAi plates
and maintained at 20uC. A group of adults was examined for
muscle dystrophies and cytosolic protein degradation at adulthood
and 24, 48, and 72 hours post adulthood. Dystrophies and
degradation were scored as positive if they appeared at any two
time points after introduction to RNAi, with particular attention to
progressive loss of cytosolic protein between the 48 and 72 hour
time points. Comparisons with previously published phenotypes
using the same RNAi clone were made using WormBase
(phenotypes: RNAi details).
Clustering genes into pathways
Mutants and drugs for clustering identified genes were as
described [7,8,9,10]. Acute RNAi experiments as described above
were conducted in wild-type, mutant and drug treated worms
carrying appropriate transgenes. Degradation was scored as above
in two independent experiments; in case of discrepancy a third
experiment was run.
Supporting Information
Figure S1 Reproducibility of developmental and/or
behavioural phenotypes produced by C. elegans RNAi
feeding vectors. A) Analysis of overall ability to observe a
consistent phenotype in our study vs. past studies using the same
feeding vectors [19,20,21]. The total number of genes examined in
this study was 159. Fractional analysis uses number of genes on the
left or percentage of 159 genes on the right (top line). Observations
were scored as consistent if any of the past reported phenotypes
were observed in this study. This analysis reveals a general
agreement but with a substantial number of inconsistencies
between this study and past studies. B) Analysis of the nature of
consistent developmental/behavioural phenotypes reported in this
and past studies. This analysis reveals the majority of consistent
phenotypic observations were the lack of a visible phenotype. C)
Analysis of the nature of inconsistent phenotypes reported in this
and past studies. Observations were scored as inconsistent if none
of the past reported phenotypes were observed in this study. This
analysis reveals that the majority of genes for which our
observations are not consistent with past observations using these
same clones we actually observed a phenotype and this observed
phenotype was consistent with the known mutant phenotype. This
analysis also reveals an inability to find convergence in phenotypes
produced 6% of the time and a known false negative rate of 3%.
D) Analysis of if RNAi clones that do not produce a
developmental/behavioural phenotype do produce a sub-cellular
defect in muscle. This analysis reveals that the majority of genes
for which RNAi treatment does not produce a phenotype (Figures
from the last lines of B and C are considered together), RNAi
treatment does produce a sub-cellular defect.
(TIF)
Figure S2 Genes that do not affect muscle protein
synthesis, degradation and/or dystrophy. Effect of RNAi
on cytosolic proteostasis, degradation, myofibrillar development,
myofibril maintenance, mitochondrial development, and/or
mitochondrial maintenance was not observed for these genes.
Each gene is named to the left. Genes are broken into classes: A)
eat mutants; B) aex, exp, pbo, dec mutants; C) mua, mup, rol mutants;
D) egl mutants; E) unc mutants. Genes within each class are
clustered by whether an organismal level phenotype was observed
(yellow) or not (white). Examples of sub-cellular phenotypes that
were scored are provided in Figure 1 and genes from the same
classes that displayed sub-cellular defects are shown in Figure 2.
(TIF)
Table S1 Comparison of developmental and behaviour-
al phenotypes observed with those previously reported.
All genes for which RNAi was used to study the effects of
decreased gene expression are listed. Alternative names for the
genes, where indexed in WormBase, are listed. The RNAi clone
used in this study is listed. Clones starting with a Roman numeral
are from the MRC library while clones starting with an Arabic
number are from the Open Biosystems library. A brief summary of
what the gene is thought or known to encode is provided based
upon the information in WormBase. Developmental and/or
behavioural phenotypes scored by us or others are listed. Details
of phenotypes scored by us can be found in Material and methods.
Details of phenotypes scored by others can be found in the
indicated references. For comparison the known mutant pheno-
type, as indexed in WormBase is provided.
(XLS)
Table S2 Genes not identified as affecting proteostasis
by mutation versus RNAi. All genes for which we failed to
detect decreased protein synthesis or increased protein degrada-
tion, by decreased level of transgenic reporter protein (see
Materials and methods), are listed. Specific alleles tested are
indicated. Five genes, where dominant alleles existed, were tested
by mutation alone. This table is a companion to Table 1, in the
main text, which displays all genes for which we did detect
decreased protein synthesis and/or increased protein degradation.
(XLS)
Sub-Cellular Defects in C. elegans Muscle Mutants
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24686
Acknowledgments
Figure 5 was generated using Biocarta’s open source pathway master
template.
Author Contributions
Conceived and designed the experiments: LAJ NJS. Performed the
experiments: FS AAA LAJ NJS. Analyzed the data: FS AAA LAJ NJS.
Wrote the paper: NJS. Constructed the figures: FS NJS.
References
1. Szewczyk NJ, Jacobson LA (2005) Signal-transduction networks and the
regulation of muscle protein degradation. Int J Biochem Cell Biol 37:
1997–2011.
2. Balch WE, Morimoto RI, Dillin A, Kelly JW (2008) Adapting proteostasis for
disease intervention. Science 319: 916–919.
3. Jarosz DF, Taipale M, Lindquist S (2010) Protein homeostasis and the
phenotypic manifestation of genetic diversity: principles and mechanisms. Annu
Rev Genet 44: 189–216.
4. Ruegg MA, Glass DJ (2011) Molecular mechanisms and treatment options for
muscle wasting diseases. Annu Rev Pharmacol Toxicol 51: 373–395.
5. Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ (2005) Molecular
mechanisms involved in muscle wasting in cancer and ageing: cachexia versus
sarcopenia. Int J Biochem Cell Biol 37: 1084–1104.
6. Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology
(Bethesda) 23: 160–170.
7. Szewczyk NJ, Hartman JJ, Barmada SJ, Jacobson LA (2000) Genetic defects in
acetylcholine signalling promote protein degradation in muscle cells of
Caenorhabditis elegans. J Cell Sci 113: 2003–2010.
8. Szewczyk NJ, Jacobson LA (2003) Activated EGL-15 FGF receptor promotes
protein degradation in muscles of Caenorhabditis elegans. EMBO J 22: 5058–5067.
9. Szewczyk NJ, Peterson BK, Jacobson LA (2002) Activation of Ras and the MAP
kinase pathway promotes protein degradation in muscle cells of Caenorhabditis
elegans. Mol Cell Biol 22: 4181–4188.
10. Szewczyk NJ, Peterson BK, Barmada SJ, Parkinson LP, Jacobson LA (2007)
Opposed growth factor signals control protein degradation in muscles of
Caenorhabditis elegans. EMBO J 26: 935–943.
11. Avery L (2010) Caenorhabditis elegans behavioral genetics: where are the
knobs? BMC Biol 8: 69.
12. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
13. Schafer WR (2005) Egg-laying WormBook. pp 1–7.
14. Avery L (1993) The genetics of feeding in Caenorhabditis elegans. Genetics 133:
897–917.
15. Thomas JH (1990) Genetic analysis of defecation in Caenorhabditis elegans.
Genetics 124: 855–872.
16. Plenefisch JD, Zhu X, Hedgecock EM (2000) Fragile skeletal muscle attachments
in dystrophic mutants of Caenorhabditis elegans: isolation and characterization
of the mua genes. Development 127: 1197–1207.
17. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and
specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
Nature 391: 806–811.
18. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, et al. (2006)
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat
Methods 3: 777–779.
19. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, et al.
(2000) Functional genomic analysis of C. elegans chromosome I by systematic
RNA interference. Nature 408: 325–330.
20. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. (2003) Systematic
functional analysis of the Caenorhabditis elegans genome using RNAi. Nature
421: 231–237.
21. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, et al. (2004) Toward improving
Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi
library. Genome Res 14: 2162–2168.
22. Fostel JL, Coste LB, Jacobson LA (2003) Degradation of transgene-coded and
endogenous proteins in the muscles of Caenorhabditis elegans. Biochem Biophys
Res Commun 312: 173–177.
23. Zdinak LA, Greenberg IB, Szewczyk NJ, Barmada SJ, Cardamone Rayner M,
et al. (1997) Transgene-coded chimeric proteins as reporters of intracellular
proteolysis: starvation-induced catabolism of a lacZ fusion protein in muscle cells
of Caenorhabditis elegans. J Cell Biochem 67: 143–153.
24. Wilkinson SB, Phillips SM, Atherton PJ, Patel R, Yarasheski KE, et al. (2008)
Differential effects of resistance and endurance exercise in the fed state on
signalling molecule phosphorylation and protein synthesis in human muscle.
J Physiol 586: 3701–3717.
25. Dillin A, Crawford DK, Kenyon C (2002) Timing requirements for insulin/IGF-
1 signaling in C. elegans. Science 298: 830–834.
26. Tischler J, Lehner B, Fraser AG (2008) Evolutionary plasticity of genetic
interaction networks. Nat Genet 40: 390–391.
27. Chen N, Harris TW, Antoshechkin I, Bastiani C, Bieri T, et al. (2005)
WormBase: a comprehensive data resource for Caenorhabditis biology and
genomics. Nucleic Acids Res 33: D383–389.
28. Reiner DJ, Weinshenker D, Thomas JH (1995) Analysis of dominant mutations
affecting muscle excitation in Caenorhabditis elegans. Genetics 141: 961–976.
29. Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, et al. (2007) Linking of
autophagy to ubiquitin-proteasome system is important for the regulation of
endoplasmic reticulum stress and cell viability. Am J Pathol 171: 513–524.
30. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, et al. (2005) The kinase
domain of titin controls muscle gene expression and protein turnover. Science
308: 1599–1603.
31. Roy PJ, Stuart JM, Lund J, Kim SK (2002) Chromosomal clustering of muscle-
expressed genes in Caenorhabditis elegans. Nature 418: 975–979.
32. Meissner B, Warner A, Wong K, Dube N, Lorch A, et al. (2009) An integrated
strategy to study muscle development and myofilament structure in Caenor-
habditis elegans. PLoS Genet 5: e1000537.
33. Peregrin-Alvarez JM, Sanford C, Parkinson J (2009) The conservation and
evolutionary modularity of metabolism. Genome Biol 10: R63.
34. Lecroisey C, Segalat L, Gieseler K (2007) The C. elegans dense body: anchoring
and signaling structure of the muscle. J Muscle Res Cell Motil 28: 79–87.
35. Katsumi A, Orr AW, Tzima E, Schwartz MA (2004) Integrins in mechan-
otransduction. J Biol Chem 279: 12001–12004.
36. Garcia SM, Casanueva MO, Silva MC, Amaral MD, Morimoto RI (2007)
Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans
post-synaptic muscle cells. Genes Dev 21: 3006–3016.
37. Mu TW, Fowler DM, Kelly JW (2008) Partial restoration of mutant enzyme
homeostasis in three distinct lysosomal storage disease cell lines by altering
calcium homeostasis. PLoS Biol 6: e26.
38. Ong DS, Mu TW, Palmer AE, Kelly JW (2010) Endoplasmic reticulum Ca2+
increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol 6:
424–432.
39. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of
autophagy. FEBS Lett 584: 1287–1295.
40. Phillips SM, Tipton KD, Aarsland A, Wolf SE, Wolfe RR (1997) Mixed muscle
protein synthesis and breakdown after resistance exercise in humans.
Am J Physiol 273: E99–107.
41. Buraei Z, Yang J (2010) The beta subunit of voltage-gated Ca2+ channels.
Physiol Rev 90: 1461–1506.
42. Staub O, Gautschi I, Ishikawa T, Breitschopf K, Ciechanover A, et al. (1997)
Regulation of stability and function of the epithelial Na+ channel (ENaC) by
ubiquitination. EMBO J 16: 6325–6336.
Sub-Cellular Defects in C. elegans Muscle Mutants
PLoS ONE | www.plosone.org 11 September 2011 | Volume 6 | Issue 9 | e24686
